Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
New treatment strategies for patients with triple-negative breast cancer
Cornelia Liedtke,
Achim Rody
Clinic of Gynecology and Obstetrics
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New treatment strategies for patients with triple-negative breast cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Triple Negative Breast Cancer
100%
Biological Marker
66%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
33%
Polyadenylic Acid
33%
Angiogenesis Inhibitor
33%
Anthracycline
33%
Polymerase
33%
Chemotherapy Agent
33%
Ribose
33%
Platinum Derivative
33%
Hormone Receptor
33%
Dose Densification
33%
Tumor Infiltrating Lymphocyte
33%
Combination Chemotherapy
33%
Pharmacology, Toxicology and Pharmaceutical Science
Triple Negative Breast Cancer
100%
Biological Marker
66%
Taxane
33%
Chemotherapy Agent
33%
Neoplasm
33%
Hormone Receptor
33%
Anthracycline
33%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
33%